中文名称:依普罗沙坦
- 依普沙坦; (E)- Α-[[2-丁基-1-[(4-羧基苯基)甲基]-1H-咪唑-5-基]亚甲基]-2-噻吩丙酸
- Eprosartan
- Eprosartan Mysylate; (E)-3-[2-Butyl-1-[(4-carboxyphenyl)-methyl]imidazol-5-l]-2-(2-thienylmethyl)-2-propenoic Acid; ((E)-3-[2-Butyl-1-[(4-carboxyphenyl)methyl]imidazol-5-yl]-2-(2-thienylmethyl)-2-propenoic Acid; SKF-108566); (E)- α-[[2-Butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-y1]methylene]2-thiophenepropanoic acid; SKF-108566J; Teveten; Eporlosartan; 4-({2-butyl-5-[2-carboxy-3-(thiophen-2-yl)prop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid; 4-({2-butyl-5-[(1E)-2-carboxy-3-thiophen-2-ylprop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid
- 133040-01-4
- C23H24N2O4S
- 424.5127
- InChI=1/C23H24N2O4S/c1-2-3-6-21-24-14-19(12-18(23(28)29)13-20-5-4-11-30-20)25(21)15-16-7-9-17(10-8-16)22(26)27/h4-5,7-12,14H,2-3,6,13,15H2,1H3,(H,26,27)(H,28,29)/b18-12+
- 1.26g/cm3
- 250-253°C
- 660.6°C at 760 mmHg
- 353.3°C
- 2.37E-18mmHg at 25°C
- 抗高血压药物。咪唑丙烯酸类血管紧张素Ⅱ受体拮抗剂。用于治疗高血压。
化工网